Paid Clinical Trials in Johns Creek, GA
As of August 2026, 35 paid clinical trials are recruiting in Johns Creek, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Johns Creek offers studies at sites including Emory Johns Creek Hospital for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Heart Failure, Atrial Fibrillation (AF), Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Johns Creek
Trials by drug in Johns Creek
Filter results
Newly added in Johns Creek
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
34 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Further MT for Antibiotic-Resistant Bacterial Colonization
Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
Top Research Study Locations in Johns Creek
Researchers run research studies in Johns Creek, GA at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Emory Johns Creek Hospital | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Advanced Esophageal Adenocarcinoma | 20 |
| NSC Research Inc | Heart Failure, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3 |
| NSC Research, Inc | Atrial Fibrillation (AF), Heart Failure, Obesity | 3 |
| Nsc Research | Cardiovascular Disease, Obesity or Overweight | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Emory Johns Creek | Lumbar Spinal Stenosis | 1 |
| Emory Orthopedics and Spine Center | Greater Trochanteric Pain Syndrome, Greater Trochanteric Pain Syndrome of Both Lower Limbs, Lateral Hip Pain | 1 |
| Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center | Achilles Tendon Injury, Ankle Injuries and Disorders, Foot Injuries and Disorders | 1 |
| Emory at Findley Road | Early Detection of Cancer, Lung Cancer Screening, Lung Neoplasms | 1 |
| NSC Research, Inc. | ASCVD, Type2Diabetes | 1 |
| One Health Research Clinic | Genitourinary Syndrome of Menopause | 1 |
Active & Upcoming Studies in Johns Creek (2026)
Recruiting trials in Johns Creek grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (18 active studies)
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) · University of California, Irvine
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Cardiovascular (8 active studies)
Diabetes & metabolic (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) · Phase 3 · Amgen
Mental health & behavior (2 active studies)
- Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) · University of California, Irvine
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain · Brixton Biosciences, Inc.
Common conditions studied in Johns Creek
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Heart Failure (3 active studies)
- Atrial Fibrillation (AF) (2 active studies)
- Breast Cancer (2 active studies)
- Hypertension (2 active studies)
- ASCVD (1 active study)
Leading research sponsors in Johns Creek
- Emory University
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Boehringer Ingelheim
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Johns Creek?
There are approximately 35 recruiting clinical trials in Johns Creek, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Johns Creek pay participants?
Most recruiting trials in Johns Creek compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Johns Creek?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Johns Creek?
The most common conditions under active study in Johns Creek include Anatomic Stage II Breast Cancer AJCC v8 (3), Heart Failure (3), Atrial Fibrillation (AF) (2), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Johns Creek?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Johns Creek on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Johns Creek?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Johns Creek?
Recruiting research sites in Johns Creek include Emory Johns Creek Hospital, NSC Research Inc, NSC Research, Inc, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Johns Creek right now?
The largest active categories in Johns Creek are Cancer & tumors (18), Cardiovascular (8), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.